1 / 7

Global Osteoporosis Drugs Market Size, Share, Trends, Growth

Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk of fracture increases. Osteoporosis primarily affects women, but can also affect men. In women, bone loss occurs rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement is too slow. Risk factors for osteoporosis include gender, age, low body weight, ethnicity, and family history. Some of the risk factors that can be manipulated include sex hormones, medication use, intake of calcium and vitamins, alcohol intake, and smoking. As per the analysts forecast the global osteoporosis drugs market to grow at a CAGR of 4.14 percent over the period 2014-2019. Get Full Report On: http://www.researchbeam.com/global-osteoporosis-drugs-2015-2019--market

BretSZavala
Download Presentation

Global Osteoporosis Drugs Market Size, Share, Trends, Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. RESEARCH BEAM SIZE FORECAST RESEARCH DEMAND Global Osteoporosis Drugs Market 2015-2019 AND SIZE MARKET AND & RESEARCH RESEARCH RESEARCH MARKET SIZE FORECAST RESEARCH DEMAND AND SIZE MARKET AND & RESEARCH RESEARCH • TELEPHONE: +1 (855) 711-1555E-MAIL:sales@researchbeam.com FORECAST

  2. ReportOverview ResearchBeam adds a report titled "Global Osteoporosis Drugs Market 2015-2019". The report provides an in-depth study on the Global Osteoporosis Drugs Market trends, opportunities and factors influencing the market. Osteoporosis, or porous bone, is a disease characterized by low bone density and structural deterioration of bone tissue, leading to fragile bones. As bones becomes fragile, risk of fracture increases. Osteoporosis primarily affects women, but can also affect men. In women, bone loss occurs rapidly in the first few years after menopause and continues through the postmenopausal stage. Osteoporosis progresses when bone resorption occurs too quickly or when replacement is too slow. Risk factors for osteoporosis include gender, age, low body weight, ethnicity, and family history. Some of the risk factors that can be manipulated include sex hormones, medication use, intake of calcium and vitamins, alcohol intake, and smoking.

  3. Covered in this report As per the analysts forecast the global osteoporosis drugs market to grow at a CAGR of 4.14 percent over the period 2014-2019. This report covers the present scenario and the growth prospects of the global osteoporosis drugs market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various osteoporosis drugs, including products with approved labeling and generic versions. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the global osteoporosis drugs market. The vendor landscape section includes a market share analysis of the major vendors along with the performances of their product portfolios.

  4. Covered in this report In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market. In addition, clinical stage pipeline molecules developed for the treatment of osteoporosis are discussed. Get Full Report On: http://www.researchbeam.com/global-osteoporosis-drugs-2015-2019--market Global Osteoporosis Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC; it also covers the global osteoporosis drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

  5. Key Regions & Vendors Key Regions • Americas • APAC • EMEA Key vendors • Amgen • Eli Lilly • Merck • Novartis Other Prominent Vendors • AbiogenPharma • Deltanoid Pharmaceuticals • F. Hoffmann La Roche • GlaxoSmithKline • IMMD

  6. Tables of Contents 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 03.1 Market Overview 03.2 Product Offerings 04. Market Research Methodology 04.1 Market Research Process 04.2 Research Methodology 05. Introduction 06. Disease Overview 06.1 Understanding Osteoporosis 06.2 Epidemiology and Demography 06.3 Risk Factors 06.4 Symptoms 06.5 Diagnosis 06.6 Treatment 07. Key Development in Osteoporosis Therapy

  7. Contact Visit us at: http://www.researchbeam.com/global-osteoporosis-drugs-2015-2019--market • TELEPHONE: +1 (855) 711-1555E-MAIL:help@researchbeam.com 5933 NE Win Sivers Drive,#205, Portland, OR 97220United States

More Related